New COVID Variant "Cicada" Under Monitoring

New COVID Variant "Cicada" Under Monitoring

Health officials are monitoring a newly identified COVID-19 variant known as BA.3.2, or “Cicada,” as it appears in multiple countries and shows early signs of circulation in the United States.

While the variant currently accounts for a small percentage of cases nationwide, it has been detected through wastewater monitoring in several states, signaling low-level spread. Experts say its high number of mutations could affect transmission and immunity, though it is too early to determine its full impact.

What to expect

Doctors report that symptoms linked to the variant appear similar to other recent strains of COVID-19, typically including:

  • Sore throat
  • Fatigue
  • Cough
  • Headache
  • Runny nose

Most cases reported so far have been described as mild.

Still, health officials are watching closely due to the variant’s mutation profile and its potential to partially evade immunity from previous infections or vaccinations. At this time, there is no indication that the variant is causing more severe illness than other circulating strains.

Louisiana monitoring closely

In Louisiana, the Department of Health is tracking the variant through laboratory testing and wastewater surveillance. Officials say the focus remains on monitoring trends and preparing for potential increases rather than issuing new mandates.

Residents are encouraged to use common-sense precautions, including staying home when sick and practicing good hygiene, as health leaders continue to watch how the variant develops.

Looking ahead

Public health experts say it is too early to determine whether the Cicada variant will lead to a noticeable increase in cases this summer, but they are preparing for the possibility.

Officials continue to recommend basic precautions, including staying home when sick, practicing good hygiene and being aware of symptoms.

As Louisiana enters the warmer months, health leaders say awareness — not alarm — remains the focus as they monitor how the variant develops.